GGrantIndex
← Leaderboards

James J. Moon

University Of Michigan At Ann Arbor

Google Scholar ↗PubMed ↗ORCID ↗
$14,172,333
Attributed
$21,579,392
Total exposure
12
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2013–25
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,579,392 · 12

By mechanism

R01$21,015,985 · 10
R56$293,407 · 1
K22$270,000 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Design”

Research focus

DesignImmune ResponseImmunityPublic HealthNanoparticleEngineeringTumorResponseT-LymphocyteT Cell ResponseSerumBenchmarkingImmunotherapyMediatingTechnologyNovel VaccinesIn VivoPropertyAntigensAdjuvantImmuneBiocompatible MaterialsImmune Checkpoint BlockadeBase

Grant awards (47)

Engineered Nano-formulations for STING Activation$654,648
R01 · FY2025 · DE · contact PI
Non-invasive and Long-lived CNS Delivery of Treg-inducing Cytokine Depots$623,579
R01 · FY2025 · EB
Biomaterials for modulating the gut microbiome for immune activation$607,815
R01 · FY2025 · CA · contact PI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer$584,137
R01 · FY2025 · DE · contact PI
Restoring the Immunogenicity of Head and Neck Cancer$559,720
R01 · FY2025 · DE
Novel nano-vaccine technology for inducing immunity against gliomas$501,930
R01 · FY2025 · NS · contact PI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer$572,454
R01 · FY2024 · DE · contact PI
Engineered Nano-formulations for STING Activation$558,881
R01 · FY2024 · DE · contact PI
Restoring the Immunogenicity of Head and Neck Cancer$555,467
R01 · FY2024 · DE
Biomaterials for modulating the gut microbiome for immune activation$542,526
R01 · FY2024 · CA · contact PI
Novel nano-vaccine technology for inducing immunity against gliomas$404,744
R01 · FY2024 · NS · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2023 · DK · contact PI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer$584,137
R01 · FY2023 · DE · contact PI
Engineered Nano-formulations for STING Activation$575,252
R01 · FY2023 · DE · contact PI
Restoring the Immunogenicity of Head and Neck Cancer$561,890
R01 · FY2023 · DE
Novel nano-vaccine technology for inducing immunity against gliomas$501,930
R01 · FY2023 · NS · contact PI
Biomaterials for modulating the gut microbiome for immune activation$483,524
R01 · FY2023 · CA · contact PI
Novel nano-vaccine technology for inducing immunity against gliomas$84,667
R01 · FY2023 · NS · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2022 · DK · contact PI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer$578,297
R01 · FY2022 · DE · contact PI
Engineered Nano-formulations for STING Activation$574,732
R01 · FY2022 · DE · contact PI
Novel nano-vaccine technology for inducing immunity against gliomas$501,930
R01 · FY2022 · NS · contact PI
Biomaterials for modulating the gut microbiome for immune activation$493,392
R01 · FY2022 · CA · contact PI
Administrative Diversity Supplement- Novel Nano-Vaccine Technology for Inducing Immunity Against Gliomas$84,667
R01 · FY2022 · NS · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2021 · DK · contact PI
New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer$584,137
R01 · FY2021 · DE · contact PI
Novel nano-vaccine technology for inducing immunity against gliomas$501,930
R01 · FY2021 · NS · contact PI
Engineering Nanomaterials to Prime Immunity$410,177
R01 · FY2021 · CA · contact PI
Elicitation of mucosal immune responses against HIV$705,624
R01 · FY2020 · AI · contact PI
Novel biomaterials for IBD treatment$634,433
R01 · FY2020 · DK · contact PI
Engineering Nanomaterials to Prime Immunity$471,122
R01 · FY2020 · CA · contact PI
Elicitation of mucosal immune responses against HIV$653,316
R01 · FY2019 · AI · contact PI
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme$423,710
R01 · FY2019 · EB · contact PI
Engineering Nanomaterials to Prime Immunity$383,908
R01 · FY2019 · CA · contact PI
Engineering Nanomaterials to Prime Immunity$73,079
R01 · FY2019 · CA · contact PI
Elicitation of mucosal immune responses against HIV$489,426
R01 · FY2018 · AI · contact PI
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme$423,710
R01 · FY2018 · EB · contact PI
Engineering Nanomaterials to Prime Immunity$394,303
R01 · FY2018 · CA · contact PI
Nanomaterials for eliciting anti-tumor T-cells-Diversity Supplement$60,840
R01 · FY2018 · CA · contact PI
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme$423,710
R01 · FY2017 · EB · contact PI
Engineering Nanomaterials to Prime Immunity$393,246
R01 · FY2017 · CA · contact PI
Elicitation of mucosal immune responses against HIV$377,893
R01 · FY2017 · AI · contact PI
Tuning Biomaterials-immune cell interactions for treatment of glioblastoma multiforme$423,710
R01 · FY2016 · EB · contact PI
Elicitation of mucosal immune responses against HIV$293,407
R56 · FY2016 · AI · contact PI
Elicitation of mucosal immune responses against HIV$94,093
R01 · FY2016 · AI · contact PI
Delivery of Particle Vaccines to Control Trafficking Patterns of T Cells$108,000
K22 · FY2014 · AI · contact PI
Delivery of Particle Vaccines to Control Trafficking Patterns of T Cells$162,000
K22 · FY2013 · AI · contact PI